Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro

American Journal of Physiology - Heart and Circulatory Physiology - Tập 296 Số 5 - Trang H1466-H1483 - 2009
Partha Mukhopadhyay1, Mohanraj Rajesh1, Sándor Bátkai1, Yoshiaki Kashiwaya2, György Haskó3, Lucas Liaudet4, Csaba Szabó5, Pál Pacher1
1National Institutes of Health, Bethesda
2NATIONAL INSTITUTES OF HEALTH
3Rutgers - The State University of New Jersey, Newark
4University of Lausanne
5University of Texas Medical Branch at Galveston

Tóm tắt

Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22phox, p40phox, p47phox, p67phox, xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit.

Từ khóa


Tài liệu tham khảo

10.1016/j.chembiol.2006.05.012

10.1016/j.yjmcc.2006.11.016

Bai P, Mabley JG, Liaudet L, Virág L, Szabó C, Pacher P.Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.Oncol Rep11: 505–508, 2004.

10.1096/fj.06-7451com

10.1152/ajpheart.00373.2007

10.1080/01926230490502601

Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C.Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.Cancer Res62: 4592–4598, 2002.

10.1007/s11010-005-9072-8

10.1016/j.cardiores.2005.07.012

10.1161/01.CIR.0000121354.34067.48

Doroshow JH, Davies KJ.Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical.J Biol Chem261: 3068–3074, 1986.

10.1161/CIRCRESAHA.107.162800

Dunn MJ.Protein Purification Applications: a Practical Approach, edited by Harris ELV, Angal S. Oxford: Oxford Univ. Press, 1989, p. 34–35.

10.1038/sj.bjp.0705080

10.1016/0014-5793(96)00086-5

10.1158/1535-7163.MCT-06-0297

10.1161/01.CIR.76.6.1422

Kawamoto K, Sha SH, Minoda R, Izumikawa M, Kuriyama H, Schacht J, Raphael Y.Antioxidant gene therapy can protect hearing and hair cells from ototoxicity.Mol Ther9: 173–181, 2004.

10.1016/j.phrs.2006.01.001

10.1089/152308601750100641

10.1161/01.RES.0000227550.00426.60

10.1016/j.freeradbiomed.2006.04.034

10.1161/CIRCULATIONAHA.105.560250

Liu B, Li H, Qu H, Sun B.Nitric oxide synthase expressions in ADR-induced cardiomyopathy in rats.J Biochem Mol Biol39: 759–765, 2006.

10.1152/ajpheart.00407.2008

10.1080/10715760802126692

10.1016/j.jacc.2006.01.073

10.1038/sj.bjp.0704495

10.1053/j.gastro.2008.06.048

Mostafa AM, Nagi MN, Al Rikabi AC, Al-Shabanah OA, El-Kashef HA.Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats.Res Commun Mol Pathol Pharmacol106: 193–202, 1999.

10.1016/j.jacc.2007.03.057

10.1038/nprot.2007.327

10.1016/j.bbrc.2007.04.106

10.1093/protein/11.10.931

10.1161/01.CIR.82.4.1352

10.1161/CIRCULATIONAHA.106.652339

10.1093/eurheartj/ehl013

10.1124/jpet.108.146423

10.1161/01.CIR.0000146889.46519.27

10.1258/0004563053492838

10.1152/physrev.00029.2006

10.1093/emboj/20.15.4107

10.1161/01.CIR.0000048192.52098.DD

10.1124/jpet.300.3.862

Pacher P, Liaudet L, Mabley JG, Cziraki A, Haskó G, Szabó C.Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.Int J Mol Med17: 369–375, 2006.

10.1038/nprot.2008.138

10.1016/j.tips.2005.04.003

10.1111/j.1527-3466.2007.00018.x

10.2353/ajpath.2008.080019

10.1016/j.yjmcc.2005.02.020

10.1016/S0891-5849(02)01111-5

10.1189/jlb.0307180

10.1158/0008-5472.CAN-08-3076

10.1146/annurev.pharmtox.47.120505.105230

10.1056/NEJM199809243391307

10.1023/A:1007094214460

10.1161/01.CIR.89.6.2829

10.1016/j.cardiores.2005.08.009

Szabó C, Ischiropoulos H, Radi R.Peroxynitrite: biochemistry, pathophysiology and development of therapeutics.Nat Rev6: 662–680, 2007.

10.1016/j.bcp.2004.11.023

10.1152/ajpheart.00024.2005

10.1254/jphs.FP0050980

10.1007/BF02940286

10.1042/bj20020752

Weinstein DM, Mihm MJ, Bauer JA.Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice.J Pharmacol Exp Ther294: 396–401, 2000.

Thông tin
Thông tin xuất bản

American Journal of Physiology - Heart and Circulatory Physiology

Tập 296 Số 5

H1466-H1483

Thông tin tác giả